Results 11 to 20 of about 36,916 (167)

Universal Quantifier PPIs

open access: yesGlossa, 2017
Negative Polarity Items (NPIs) that denote lower scalar endpoints, such as existentials like any or ever, are often said to be only fine in Downward Entailing contexts, since outside such contexts their semantics would give rise to a contradiction ...
Hedde Zeijlstra
doaj   +5 more sources

Proton-pump inhibitors

open access: yesSouth African Family Practice, 2015
Proton-pump inhibitors (PPIs) are a class of drugs that profoundly suppress gastric acid secretion, and thus have become the treatment of choice for gastro-oesophageal reflux disease and peptic ulcer disease. PPIs are considered safe and effective. It is
Vasudevan G. Naidoo
doaj   +1 more source

A large accessory protein interactome is rewired across environments

open access: yeseLife, 2020
To characterize how protein-protein interaction (PPI) networks change, we quantified the relative PPI abundance of 1.6 million protein pairs in the yeast Saccharomyces cerevisiae across nine growth conditions, with replication, for a total of 44 million ...
Zhimin Liu   +4 more
doaj   +1 more source

Update on the management of eosinophilic esophagitis in adult patients [PDF]

open access: yesExploration of Asthma & Allergy
Eosinophilic esophagitis (EoE) is an adaptive immune T-cell-mediated type 2 inflammatory disease involving the esophagus. Major advances were made in diagnosis and therapy for EoE in the last decade.
Adrianna Wierzbicka, Andrew Ukleja
doaj   +1 more source

Modified PPIs (a search for the better)

open access: yesAl-Azhar Assiut Medical Journal, 2016
'Modified PPIs' is the term given to proton pump inhibitors (PPIs) introduced after the four conventional PPIs – omeprazole, lansoprazole, pantoprazole, and rabeprazole – all of which have similar actions and limitations and are produced by similar ...
Hussein Abdel-Hamid
doaj   +1 more source

Evaluation of Proton Pump Inhibitors Prescribing Among Hospitalized Patients: A Cross-Sectional Study

open access: yesInternational Journal of General Medicine, 2023
Abdallah Damin Abukhalil, Ola Ali,* Asmaa Saad,* Hiba Falana, Ni’meh Al-Shami, Hani A Naseef, Abdullah Rabba Pharmacy Department, Faculty of Pharmacy, Nursing and Health Professions, Birzeit University, Birzeit, West Bank, Palestine*These ...
Abukhalil AD   +6 more
doaj  

Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options

open access: yesSouth African Family Practice, 2016
Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g.
Gustav Schellack   +2 more
doaj   +1 more source

Impact of proton pump inhibitors on the in-hospital outcome of COVID-19 patients: a retrospective study

open access: yesTherapeutic Advances in Gastroenterology, 2022
Background: Coronavirus disease 2019 (COVID-19) has triggered a global public health crisis. Proton pump inhibitors (PPIs) are one of the most commonly prescribed drugs.
Haijuan Yao   +16 more
doaj   +1 more source

An investigation performed in a Bangladeshi general hospital on the use of proton pump inhibitors drugs by patients [PDF]

open access: yesHospital Pharmacology
Introduction: Proton pump inhibitors (PPIs) are anti-ulcer drugs that have reportedly been used inappropriately in therapeutic settings, raising the risk of adverse effects, drug interactions , and costs.
Sony Tahmina Akter   +2 more
doaj   +1 more source

Test-Retest reliability of prepulse inhibition (PPI) and PPI correlation with working memory [PDF]

open access: yesActa Neuropsychiatrica, 2021
Abstract Sensorimotor gating – a mechanism to filter sensory input and regulate motor output - is experimentally operationalized by the prepulse inhibition (PPI) of the startle response (SR). Previous studies suggest high test-retest reliability of PPI and potential correlation with working memory (WM).
Florian Freudenberg   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy